Fiber and prebiotics: mechanisms and health benefits

Joanne Slavin, Joanne Slavin

Abstract

The health benefits of dietary fiber have long been appreciated. Higher intakes of dietary fiber are linked to less cardiovascular disease and fiber plays a role in gut health, with many effective laxatives actually isolated fiber sources. Higher intakes of fiber are linked to lower body weights. Only polysaccharides were included in dietary fiber originally, but more recent definitions have included oligosaccharides as dietary fiber, not based on their chemical measurement as dietary fiber by the accepted total dietary fiber (TDF) method, but on their physiological effects. Inulin, fructo-oligosaccharides, and other oligosaccharides are included as fiber in food labels in the US. Additionally, oligosaccharides are the best known "prebiotics", "a selectively fermented ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microflora that confers benefits upon host well-bring and health." To date, all known and suspected prebiotics are carbohydrate compounds, primarily oligosaccharides, known to resist digestion in the human small intestine and reach the colon where they are fermented by the gut microflora. Studies have provided evidence that inulin and oligofructose (OF), lactulose, and resistant starch (RS) meet all aspects of the definition, including the stimulation of Bifidobacterium, a beneficial bacterial genus. Other isolated carbohydrates and carbohydrate-containing foods, including galactooligosaccharides (GOS), transgalactooligosaccharides (TOS), polydextrose, wheat dextrin, acacia gum, psyllium, banana, whole grain wheat, and whole grain corn also have prebiotic effects.

References

    1. Slavin J.L. Dietary fiber: Classification, chemical analyses, and food sources. J. Am. Diet. Assoc. 1987;87:1164–1171.
    1. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995;125:1401–1412.
    1. Gibson G.R., Probert H.M., van Loo J., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr. Res. Rev. 2004;17:259–275. doi: 10.1079/NRR200479.
    1. Roberfroid M., Gobson G.R., Hoyles L., McCartney A.L., Rastall R., Rowland I., Wolvers D., Watzl B., Szajewska H., Stahl B., et al. Prebiotic effects: Metabolic and health benefits. Br. J. Nutr. 2011;104:S1–S63.
    1. Leach J.D., Sobolik K.D. High dietaryintake of prebiotic inulin-type fructans in the prehistoric Chihauhuan desert. Br. J. Nutr. 2010;103:1158–1561.
    1. Van Loo J., Coussement P., de Leenheer L., Hoebregs H., Smits G. On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit. Rev. Food Sci. Nutr. 1995;35:525–552. doi: 10.1080/10408399509527714.
    1. Livesey G. The energy values of dietary fibre and sugar alcohols for man. Nutr. Res. Rev. 1992;5:61–84. doi: 10.1079/NRR19920007.
    1. Lied G.A., Lillestol K., Lind R., Valeur J., Morken M.H., Vaali K., Gregersen K., Florvaag E., Tangen T., Berstad A. Perceived food hypersensitivity: A review of 10 years of interdisciplinary research at a reference center. Scan. J. Gastroenterol. 2011;40:1169–1178.
    1. Grabitske H.A., Slavin J.L. Gastrointestinal effects of low-digestible carbohydrates. Crit. Rev. Food Sci. Nutr. 2009;49:327–360. doi: 10.1080/10408390802067126.
    1. Pasman W., Wils D., Saniez M.H., Kardinaal A.F. Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men. Eur. J. Clin. Nutr. 2006;60:1024–1034. doi: 10.1038/sj.ejcn.1602418.
    1. Gibson G.R., Scott K.P., Rastall R.A., Tuohy K.M., Hotchkiss A., Dubert-Ferrandon A., Gareau M., Murphy E.F., Saulnier D., Loh G., et al. Dietary prebiotics: Current status and new definition. Food Sci. Technol. Bull. Funct. Foods. 2010;7:1–19. doi: 10.1616/1476-2137.15880.
    1. Cummings J.H., Macfarlane G.T. The control and consequences of bacterial fermentation in the human colon. J. Appl. Bacteriol. 1991;70:443–459. doi: 10.1111/j.1365-2672.1991.tb02739.x.
    1. Gordon J.I., Ley R.E., Wilson R., Mardis E., Xu J., Fraser C.M., Relman D.A. Extending our view of self: The Human Gut Microbiome Initiative (HGMI) [(accessed on 8 October 2011)]. Available online: .
    1. Lupton J.R. Microbial degradation products influence colon cancer risk: The butyrate controversy. J. Nutr. 2004;134:479–482.
    1. DeFillippo F.C., Cavallieri D., Di P.M., Ramazzotti M., Pouliet J.B., Massart S., Collini S., Pieraccini G., Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA. 2010;107:14691–14696. doi: 10.1073/pnas.1005963107.
    1. Brownawell A.M., Caers W., Gibson G.R., Kendall C.W.C., Lewis K.D., Ringel Y., Slavin J.L. Prebiotics and the health benefits of fiber: Current regulatory status, future research, and goals. J. Nutr. 2012;142:1–13. doi: 10.3945/jn.111.148155.
    1. Slavin J.L. Position of the American Dietetic Association: Health implications of dietary fiber. J. Am. Diet. Assoc. 2008;108:1716–1731. doi: 10.1016/j.jada.2008.08.007.
    1. Howlett J.J., Betteridge V.A., Champ M., Craig S.A.S., Meheust A., Jones J.M. The definition of dietary fiber—Discussions at the Ninth Vahouny Fiber Symposium: Building scientific agreement. Food Nutr. Res. 2010;54 doi: 10.3402/fnrv5405750.
    1. Jones J.M. Dietary Fibre’s Co-Passengers: Is It the Fibre or the Co-Passengers? In: van der Kamp J.W., Jones J., Mccleary B., Topping D.J., editors. Dietary Fiber: New Frontiers for Food and Health. Wageningen Academic Publishers; Wageningen, The Netherlands: 2010. pp. 365–378.
    1. Slavin J.L., Savarino V., Parades-Diaz A., Fotopoulos G. A review of the role of soluble fiber in health with specific reference to wheat dextrin. J. Int. Med. Res. 2009;37:1–17.
    1. Spahn J.M., Lyon J.M., Altman J.M., Blum-Kemelor D.M., Essery E.V., Fungwe T.V., Macneil P.C., McGrane M.M., Obbagy J.E., Wong V.P. The systematic review methodology used to support the 2010 Dietary Guidelines Advisory Committee. J. Am. Diet. Assoc. 2011;111:520–523. doi: 10.1016/j.jada.2011.01.005.
    1. Hopping B.N., Erber E., Grandinetti A., Park S.Y., Kolonel L.N., Maskarinec G. Dietary fiber, magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort in Hawaii. J. Nutr. 2010;140:68–74. doi: 10.3945/jn.109.112441.
    1. Meyer K.A., Kushi L.H., Jackobs D.R., Slavin J., Sellers A.A., Folsom A.R. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am. J. Clin. Nutr. 2000;71:921–830.
    1. Biorklund M., Rees A., van Mensink R.P., Onning G. Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with beta-glucans from oats or barley: A randomized dose controlled trial. Eur. J. Clin. Nutr. 2005;59:1272–1281. doi: 10.1038/sj.ejcn.1602240.
    1. Nazare J.A., Sauvinet V., Normand S., Guerin-Deremaux L., Gabert L., Desige M., Wils D., Laville M. Impact of a resistant dextrin with a prolonged oxidation pattern on day-long ghrelin profile. J. Am. Coll. Nutr. 2011;30:63–72.
    1. Mathern J.R., Raatz S.K., Thomas W., Slavin J.L. Effect of fennugreek fiber on satiety, blood glucose and insulin response and energy intake in obese subjects. Phytother. Res. 2009;23:1543–1548. doi: 10.1002/ptr.2795.
    1. Cummings J.H. The Effect of Dietary Fiber on Fecal Weight and Composition. In: Spiller G.A., editor. CRC Handbook of Dietary Fiber in Human Nutrition. CRC Press; Boca Raton, FL, USA: 1993. pp. 263–333.
    1. Slavin J., Feirtag J. Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects. Food Funct. 2011;2:72–77. doi: 10.1039/c0fo00101e.
    1. Bonnema A.L., Kohlberg L.W., Thomas W., Slavin J.L. Gastrointestinal tolerance to chicory inulin products. J. Am. Diet. Assoc. 2010;110:865–868. doi: 10.1016/j.jada.2010.03.025.
    1. Grabitske H.A., Slavin J.L. Low-digestible carbohydrates in practice. J. Am Diet Assoc. 2008;108:1677–1681. doi: 10.1016/j.jada.2008.07.010.
    1. Slavin J., Green H. Dietary fibre and satiety. Nutr. Bull. 2007;32:32–42. doi: 10.1111/j.1467-3010.2007.00603.x.
    1. Chaudhri O.B., Salem V. Gastrointestinal satiety signals. Annu. Rev. Physiol. 2008;70:239–255. doi: 10.1146/annurev.physiol.70.113006.100506.
    1. Guerin-Deremaux L., Pochat M., Reifer C., Wils D., Cho S., Miller L.E. The soluble fiber Nutriose induces a dose dependent beneficial impact on satiety over time in humans. Nutr. Res. 2011;31:665–672. doi: 10.1016/j.nutres.2011.09.004.
    1. Tucker L.A., Thomas K.S. Increasing total fiber intake reduces risk of weight and fat gains in women. J. Nutr. 2009;139:576–581. doi: 10.3945/jn.108.096685.
    1. Howarth N.C., Saltzman E., Roberts S.B. Dietary fiber and weight regulation. Nutr. Rev. 2001;59:129–139. doi: 10.1111/j.1753-4887.2001.tb07001.x.
    1. Ley R.E., Turnbaugh P.J., Klein S., Gordon J. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444:1027–1031. doi: 10.1038/nature05414.
    1. Musso G., Gambino R., Cassader M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: Mechanisms and implications for metabolic disorders. Curr. Opin. Lipidol. 2010;21:76–83. doi: 10.1097/MOL.0b013e3283347ebb.
    1. Lanza E., Yu B., Murphy G., Albert P.S., Chan B., Marshall J.R., Lance P., Paskett E.D., Weissfeld J., Slattery M., et al. The polyp prevention trial continued follow-up study: No effect of a low-fat, high-fiber, high-fruit and vegetable diet on adenoma recurrence eight years after randomization. Cancer Epidemiol. Biomarkers Prev. 2007;16:1745–1752. doi: 10.1158/1055-9965.EPI-07-0127.
    1. Costabile A., Kolida S., Klinder A., Gietl E., Bauerlein M., Frohburg C., Landschutze V., Gibson G.R. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long chain inulin extracted from globe artichoke (Cynara scolymus) in healthy subjects. Br. J. Nutr. 2010;104:1007–1017. doi: 10.1017/S0007114510001571.
    1. Ramnani P., Gaudier E., Bingham M., van Bruggen P., Tuohy K.M., Gibson G.R. Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: A human intervention study. Br. J. Nutr. 2010;104:233–240. doi: 10.1017/S000711451000036X.
    1. Calame W., Weseler A.R., Viebke C., Flynn C., Siemensma A.D. Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner. Br. J. Nutr. 2008;100:1269–1275. doi: 10.1017/S0007114508981447.
    1. Jie Z., Bang-Yao J., Ming-Jie X., Hai-wei L., Zu-kang Z., Ting-song W., Craig S.A.S. Studies on the effects of polydextrose intake on physiologic functions in Chinese people. Am. J. Clin. Nutr. 2000;72:1503–1509.
    1. Hengst C., Ptok S., Roessler A., Fechner A., Jahreis G. Effects of polydextrose supplementation on different faecal parameters in healthy volunteers. Int. J. Food Sci. Nutr. 2009;60:96–105. doi: 10.1080/09637480802526760.
    1. Lefranc-Millot C., Gruerin-Deremaux L., Wils D., Neut C., Miller L.E., Saniez-Degrave M.H. Impact of a resistant dextrin on intestinal ecology: How altering the digestive ecosystem with NUTRIOSE, a soluble fiber with prebiotic properties, may be beneficial for health. J. Int. Med. Res. 2012;40:211–224.
    1. Eli M., Cattivelli D., Soldi S., Bonatti M., Morelli L. Evaluation of prebiotic potential of refined psyllium (Plantago ovata) fiber in healthy women. J. Clin. Gastroenterol. 2008;42:S174–S176. doi: 10.1097/MCG.0b013e31817f183a.
    1. Costabile A., Klinder A., Fava F., Napolitano A., Fogliano V., Leonard C., Gibson G.R., Tuohy K.M. Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: A double-blind, placebo-controlled, crossover study. Br. J. Nutr. 2008;99:110–120.
    1. Carvalho-Wells A.L., Helmolz K., Nodet C., Molzer C., Leonard C., McKevith B., Thielecke F., Jackson K.G., Tuohy K.M. Determination of the in vivo prebiotic potential of a maize-based whole grain breakfast cereal: A human feeding study. Br. J. Nutr. 2010;104:1353–1356. doi: 10.1017/S0007114510002084.
    1. Mitsou E.K., Kougia E., Nomikos T., Yannakoulia M., Mountzouris K.C., Kyriaacou A. Effect of banana consumption on faecal microbiota: A randomized, controlled trial. Anaerobe. 2011;17:384–387. doi: 10.1016/j.anaerobe.2011.03.018.
    1. Watson D., O’Connell Moterway M., Schoterman M.H.C., Joost van Neerven R.J., Nauta A., van Sinderen D. Selective carbohydrate utilization by lactobacilli and bifidobacteria. J. Appl. Microbiol. 2012 doi: 10.1111/jam.12105.
    1. Saavedra J.M., Tschernia A. Human studies with probiotics and prebiotics: Clinical implications. Br. J. Nutr. 2002;87:S241–S246.
    1. Parisi G.C., Zilli M., Miani M.P., Carrara M., Verdianelli G., Battaglia G., Desidera S., Faedo A., Malzolino C., Tonon A., et al. High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): A multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG) Dig. Dis. Sci. 2002;47:1697–1704.
    1. Chuang S.C., Norat T., Murphy N., Olsen A., Tjonneland A., Overvad K., Boulton-Ruell M.C., Perquier F., Dartois L., Kaaks R., et al. Fiber intake and total and cause-specific mortality in the European prospective investigation into Cancer and Nutrition cohort. Am. J. Clin. Nutr. 2012;96:164–174. doi: 10.3945/ajcn.111.028415.
    1. Cummings J.H., Christie S., Cole T.J. A study of fructo oligosaccharides in the prevention of travellers’ diarrhoea. Aliment. Pharmacol. Ther. 2001;15:1139–1145. doi: 10.1046/j.1365-2036.2001.01043.x.
    1. Drakoularakou A., Tzortzis G., Rastall R.A., Gibson G.R. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea. Eur. J. Clin. Nutr. 2010;64:146–152. doi: 10.1038/ejcn.2009.120.
    1. Konikoff M.R., Denson L.A. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm. Bowel. Dis. 2006;12:524–534. doi: 10.1097/00054725-200606000-00013.
    1. Silk D.B., Davis A., Vulevic J., Tzortzis G., Gibson G.R. Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 2009;29:508–518. doi: 10.1111/j.1365-2036.2008.03911.x.
    1. Boutron-Ruault M.C., Marteau P., Lavergne-Slove A., Myara A., Gerhardt M.F., Franchisseur C., Bornet F. Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas. Nutr. Cancer. 2005;53:160–168. doi: 10.1207/s15327914nc5302_5.
    1. Limburg P.J., Mahoney M.R., Ziegler K.L., Sontag S.J., Schoen R.E., Benya R., Lawson M.J., Weinberg D.S., Stoffel E., Chiorean M., et al. Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. Cancer Prev. Res. (Phila.) 2001;4:259–269.
    1. Abrams S.A., Griffin I.J., Hawthorne K.M., Liang L., Gunn S.K., Darlington G., Ellis K.J. A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am. J. Clin. Nutr. 2005;82:471–476.
    1. Martin B.R., Braan M.D., Wigertz K., Bryant R., Zhao Y., Lee W., Kempa-Steczko S., Weaver C.M. Fructo-oligosaccharides and calcium absorption and retention in adolescent girls. J. Am. Coll. Nutr. 2010;29:382–386.
    1. Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. National Academies Press; Washington, DC, USA: 2002.
    1. Forcheron F., Beylot M. Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism. 2007;56:1093–1098. doi: 10.1016/j.metabol.2007.03.019.
    1. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 2005;102:11070–11075.
    1. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., Sogin M.L., Jones W.J., Roe B.A., Affourtit J.P., et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480–484.
    1. Parnell J.A., Reimer R.A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 2009;89:1751–1759.
    1. Cani P.D., Lecourt E., Dewulf E.M., Sohet F.M., Pachikian B.D., Naslain D., De B.F., Neyrinck A.M., Delzenne N.M. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 2009;90:1236–1243. doi: 10.3945/ajcn.2009.28095.
    1. Hess J.R., Birkett A.M., Thomas W., Slavin J.L. Effects of short-chain fructooligosaccharides on satiety responses in healthy men and women. Appetite. 2011;56:128–134. doi: 10.1016/j.appet.2010.12.005.
    1. Guerin-Deremaux L., Li S., Pochat M., Wils D., Mubasher M., Reifer C., Miller L.E. Effets of Nutriose dietary fiber supplementation on body weight, body composition, energy intake, and hunger in overweight men. Int. J. Food Sci. Nutr. 2011;62:628–635. doi: 10.3109/09637486.2011.569492.
    1. US Department of Agriculture. Carbohydrates (Dietary Guidelines for Americans) 2010. [(accessed on 6 October 2011)]. Available online: .
    1. EFSA Panel on Dietetic Products Nutrition and Allergies. Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J. 2011;9:1984.
    1. Pineiro M., Asp N.G., Reid G., Macfarlane S., Morelli L., Brunser O., Tuhy K. FAO Technical meeting on prebiotics. J. Clin. Gastroenterol. 2008;42:S156–S159. doi: 10.1097/MCG.0b013e31817f184e.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe